ADVFN - Advanced Financial Network.
HOME» NYSE » O » OCR Stock Price » OCR Stock News

Omnicare Share News

 Omnicare Inc. Stock Price
OCR Stock Price
 Omnicare Inc. Stock Chart
OCR Stock Chart
 Omnicare Inc. Stock News
OCR Stock News
 Omnicare Inc. Company Information
OCR Company Information
 Omnicare Inc. Stock Trades
OCR Stock Trades

Omnicare Swings To 2Q Loss On Charges, Discontinued Operations

DOW JONES NEWSWIRES Omnicare Inc. (OCR) swung to a second-quarter loss on litigation-related charges and a sharply wider loss at its discontinued operations, which included the contract-service business that the company sold in April. Adjusted profit from continuing operations and revenue beat analysts' expectations. The provider of drugs to nursing homes and assisted-living centers has seen its bottom line hurt by litigation charges and other expenses in recent quarters. Omnicare has been working to recover from turmoil that apparently led to a management upheaval last year. The company has been trying to build up its drug-distribution business and shed noncore operations. Omnicare reported a loss of $1.5 million, or a penny a share, from a year-earlier profit of $11.6 million, or 10 cents a share. Excluding litigation-related charges, earnings from continuing operations were up at 50 cents from 49 cents. Revenue increased 4.3% to $1.56 billion. Analysts polled by Thomson Reuters most recently forecast earnings of 49 cents on revenue of $1.53 billion. Gross margin edged down to 21.6% from 21.9%. Shares of Omincare, which affirmed its 2011 guidance, closed Monday at $30.39 and were inactive premarket. The stock is up 59% from a two-year low in August following the abrupt departure of its management team. -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stock News for Omnicare (OCR)
DateTimeHeadline
03/25/201409:41:12U.S. Hot Stocks: Hot Stocks to Watch
02/19/201409:51:22U.S. Stocks: Hot Stocks to Watch
12/05/201309:04:04U.S. Hot Stocks Futures: Hot Stocks to Watch
11/15/201309:18:03OZ Management LP 3Q 13F: Largest Purchases -2-
11/15/201309:18:02OZ Management LP 3Q 13F: Largest Purchases
11/15/201309:18:02OZ Management LP 3Q 13F: Holdings As Of Sep 30 -2-
11/15/201309:18:02OZ Management LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:22:24Janus Capital Management 3Q 13F: Holdings As Of -2-
11/15/201308:22:23Janus Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201308:21:52Janus Capital Management 3Q 13F: Largest Purchases -2-
11/15/201308:21:50Janus Capital Management 3Q 13F: Largest Sales
11/15/201307:11:08AQR Capital Management 3Q 13F: Holdings As Of Sep -2-
11/15/201307:11:08AQR Capital Management 3Q 13F: Holdings As Of Sep 30
04/16/201317:30:14Amgen to Pay $24.9 Million to Settle Kickbacks Allegations
04/16/201317:23:12Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks
01/30/201309:49:57AmerisourceBergen Signs New Deal With Big Customer PharMerica
06/08/201218:10:09J&J to Record $600 Million Charge in 2Q
06/08/201218:03:22J&J to Record $600 Million Charge Tied to Outstanding Lawsuits
04/25/201217:16:50J&J New CEO: Top Job Is Fixing Over-The-Counter Drug Business
04/13/201214:10:39US Wants To Question Incoming J&J CEO In Kickback Lawsuit

Omnicare and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad